HIGH

See Luer Cap Set, MPC-130, set, administration, intravascular

Molded Products, Inc. is voluntarily conducting a medical device recall of the MPC-130 See Luer Cap Set based on a confirmed complaint of the threaded sleeve not being engaged and becoming un-attached.

Quick Facts at a Glance

Recall Date
February 17, 2026
Hazard Level
HIGH
Brand
Molded Products
Geographic Scope
1 states

Hazard Information

Molded Products, Inc. is voluntarily conducting a medical device recall of the MPC-130 See Luer Cap Set based on a confirmed complaint of the threaded sleeve not being engaged and becoming un-attached.

What You Should Do

Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact Molded Products Inc or your healthcare provider for instructions. Notification method: Letter

Get instant alerts for Molded Products recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

Full Description

See Luer Cap Set, MPC-130, set, administration, intravascular. Reason: Molded Products, Inc. is voluntarily conducting a medical device recall of the MPC-130 See Luer Cap Set based on a confirmed complaint of the threaded sleeve not being engaged and becoming un-attached.. Classification: Class II. Quantity: 26900 units. Distribution: US Nationwide distribution in the states of TN, TX, NV, IL, FL.

View Original Recall on FDA - Medical Devices

Browse More Recalls

More from FDA_DEVICEHealth & Personal CareMedical Devices

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: How to Get Refunds and Replacements

Want to Know First?

Get instant alerts for recalls that affect you. Free forever.

Product Classification

Product Details

Model Numbers
UDI +B144MPC1300/$$529105203895
Lot Number 20389
Affected States
ALL
Report Date
April 15, 2026
Recall Status
ACTIVE

Related Recalls

Health & Personal Care
HIGH

K.C. Pharmaceuticals Recalls 8 OTC Eye Drops for Sterility Concerns (2026)

K.C. Pharmaceuticals recalled eight OTC eye drops sold nationwide under CVS Health, Walgreens and Kroger brands after sterility could not be verified. The recall covers all lots within expiry through Oct 31, 2026. Nonsterile eye drops can harbor bacteria and fungus, causing serious infections that may lead to vision loss. Stop using recalled products and return them for a full refund at the store.

K.C. Pharmaceuticals
Nonsterile eye
Read more
Health & Personal Care
HIGH

Biocon Pharma Prazosin Hydrochloride 1mg 100-Count Capsules Recalled for Nitrosamine Impurity (2026)

Biocon Pharma Inc. recalled 88,008 bottles of Prazosin Hydrochloride capsules, 1 mg, 100-count bottles, nationwide in the United States. A cGMP deviation detected N-nitroso-prazosin impurity C above acceptable limits. Consumers and healthcare providers should stop using this product immediately and contact Appco Pharma LLC or a healthcare provider for guidance.

Biocon Pharma
cGMP deviation:
Read more
Health & Personal Care
HIGH

Biocon Pharma Prazosin Hydrochloride 5mg Recall 28,157 Bottles Over Nitrosamine Impurity (2026)

Biocon Pharma Inc. recalled 28,157 bottles of PRAZOSIN HYDROCHLORIDE capsules, distributed nationwide in the USA. The recall cites cGMP deviation due to detection of N-nitroso-prazosin impurity C above acceptable limits. Stop using the product immediately and contact Appco Pharma LLC or your healthcare provider for guidance.

Prazosin Hydrochloride
cGMP deviation:
Read more
Health & Personal Care
HIGH

Biocon Prazosin Hydrochloride 2 mg Capsules Recalled for Nitrosamine Impurity (58,896 bottles, 2026)

Biocon Pharma Inc. recalled 58,896 bottles of Prazosin Hydrochloride Capsules, USP, 2 mg, 100-count bottle. The product was distributed nationwide in the USA and manufactured by Appco Pharma LLC. A cGMP deviation detected N-nitroso-prazosin impurity C above acceptable limits. Consumers and healthcare providers should stop using this product immediately and contact Appco Pharma LLC or their health‑

Prazosin Hydrochloride
cGMP deviation:
Read more